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Dear editor,
The high occurrence of nosocomial multidrug-resistant 
microorganisms is considered a global health problem and 
although the presence and transmission of these microor-
ganisms is most frequently documented in recent decades 
in acute care facilities, all healthcare settings are affected. 
This implies that the approaches in the prevention and 
control of these pathogens have to be adapted to the 
specific needs (own risk factors) of each institution.1 In 
Brazil, regard its continental dimensions, with macro 
and micro-regional differences in relation to existing 
hospitals, and problems of assisted population and avai-
lable resources, bacterial resistance in hospitals offering 
tertiary care leads a significant problem and a challenge 
of the patient treatment. The antibiotic therapy in these 
hospitals is commonly overused and often little judicious. 
In addition, the absence of microbiology laboratories 
favors the incorrect prescription, and the lack of a na-
tional reference laboratory is another barrier to better 
understanding of these microorganisms as well as the 
epidemiology of infections, resulting in poor scientific 
documentation.2
The hospital microbiota responsible for the etiology 
of health care-associated infections has been modulated 
through the years by the most prescribed antibiotics, and 
to a lesser extent, by advances in medical technology as 
the increasing use of indwelling devices and prostheses.1 
Approximately 40% of hospitalized patients receive an-
tibiotics, however, in about 50% of the cases, the use of 
antimicrobials is unnecessary.3 Empirical therapy, paticu-
larly in critical units, is used with a combination of several 
broad-spectrum antibiotics, allowing multidrug-resistant 
strains such as Methicillin-resistant Staphylococcus aureus 
(MRSA), Gram-negative non-fermentative bacteria and 
Enterobacteriacae family particularly those producing 
metallo-ß-lactamase  and extended spectrum ß-lacta-
mase to emerge and spread quickly.
Besides the strength of selection pressure of 
antibiotics, amplified by inadequate empirical use of 
potent and broad-spectrum antibiotics, other factors 
are also important in the epidemiology of infections by 
these microorganisms, including: 1) critically ill patients 
in intensive care units, that are often exposed to invasive 
devices, and frequently acquire associated infections,1,4 
2) the current social mobility, with international air travel 
predominantly for tourism, and more recently associated 
with major events, with the FIFA World Cup 2014 and 
Olympic Games in Rio de Janeiro 2016; 3) poor imple-
menting of infection prevention and control practices by 
the lack of human, both in qualitative and quantitative 
terms, and financial resources contribute for intra- and 
inter-hospital transmission of pathogens and finally 4) 
the existence of clones, with better adaptation in the 
hospital environment and faster spread capacity due to 
the “fitness” to adjust its metabolism to new genes of 
exogenous origin.5,6
In each prescription of antibiotics there is an ecolo-
gical and environmental consequence. Their use not only 
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educational campaigns directed to health professionals, 
monitoring of antibiotic consumption and resistance and 
infections rates.
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selects and maintains resistant microorganisms in the 
environment, but also increases their spread.1,6 Today, the 
better diagnosis, more information on the ecology and 
local epidemiology, access to information of the severity 
of the condition, risk factors for developing infections, 
knowledge of pharmacokinetics and pharmacodynamics 
of antibiotics, better the prognosis for the patient.
Antibiotics represent a precious reserve as a drug, 
therefore it is required your protection through programs 
and policy measures that limit their inappropriate use not 
only for humans, also for animals for human consump-
tion and aquaculture, as well as to ensure compliance to 
those practices relating to the use of these medicines in 
hospitals, hand hygiene and other important infection 
control measures.5 Also, recently, increasing attention to 
environmental sources of selective pressure antibiotics, 
considering that the treatment of wastewater hospitals, 
municipalities, the pharmaceutical industry and agriculture 
have also been recognized as sources of environmental 
exposure to antibiotics and antibiotic resistance genes.7  
Countries like Brazil, characterized by the allocation 
of limited financial resources for the health department, 
have in the infection prevention and control practices 
an economical necessity, because of the increased costs 
that nosocomial infection demand in addition to the 
reduction of rates morbidity and mortality. Despite this 
scenario of the current slump and restrictions of Brazilian 
market on the use of antibiotics, it takes more effort and 
commitment of hospital managers and governments on 
how to develop an appropriate and effective policy to 
reduce the empirical and inappropriate use of antibiotics, 
particularly in the context of the health system reform. 
In addition, more comprehensive strategies should in-
volve other components that are considered essential as 
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